Bottom line Medications affect people differently, and although anxiety isnt a common side effect of Wegovy, it is possible
Tirzepatide (Zepbound) A New Treatment for Obstructive Sleep Apnea and Obesity In December 2024, the FDA approved Tirzepatide (Zepbound) for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity
Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, et al
Tm hiu thm: Collagen Peptides l g
Together, these findings indicate that reactive nitrogen species promote TTR crosslinking through reversible thiol activation, whereas strong oxidants divert cysteine chemistry toward stable overoxidized states that suppress disulfide-mediated conversion